Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–15 of 15 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT04545762
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT05934448
- Conditions
- Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma Recurrent, +3 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
- Locations
-
- Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
- Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
- Napa Research Pompano Beach, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT05326243
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, Follicular Lymphoma Grade 3B, +13 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
- Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
- Chi Mei Medical Center Tainan, Taiwan
- Taipei Medical University - Taipei Medical University Hospital Taipei, Taiwan
NCT05377307
- Conditions
- Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Grade 3A, +16 more
- Locations
-
- Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung, Taiwan
- National Taiwan University Hospital Taipei, Taiwan
- Taipei Veterans General Hospital Taipei, Taiwan
- Chi Mei Medical Center Tainan, Taiwan
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
NCT07225439
- Conditions
- B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
- Locations
-
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
NCT05653271
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
- Locations
-
- AdventHealth Orlando Orlando, Florida, United States
- Emory University Atlanta, Georgia, United States
- Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Norton Cancer Institute Louisville, Kentucky, United States
NCT04488354
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California at San Diego San Diego, California, United States
- University of Chicago Chicago, Illinois, United States
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
NCT04067414
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT01516567
- Conditions
- Primary Mediastinal Large B Cell Lymphoma
- Locations
-
- University Hospitals Leuven Leuven, Belgium
- Children Oncology Group Operations centres Monrovia, Canada
- Gustave Roussy Villejuif, France
- 2nd Dept. of Pediatrics Semmelweis Univ. Budapest, Hungary
NCT04450069
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California at San Diego San Diego, California, United States
- University of Chicago Chicago, Illinois, United States
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
NCT04323657
- Conditions
- Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +20 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT02423291
- Conditions
- Primary Mediastinal Large B Cell Lymphoma
- Locations
-
- S.C. Ematologia A.O. SS. Antonio e Biagio e C. Arrigo Alessandria, AL, Italy
- Unità funzionale di Ematologia A.O.U. Careggi Florence, FI, Italy
- Dip. Oncologia, Ematologia e Patologie dell'apparato respiratorio A.O.U. Policlinico di Modena Modena, MO, Italy
- Divisione di Ematologia Azienda Ospedaliera "Bianchi Melacrino Morelli" Reggio Calabria, RC, Italy
Trial of the Safety and Efficacy of Epcoritamab in Japanese Subjects With Relapsed or Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (R/R B-NHL)
NCT04542824
- Conditions
- Chronic Disease, Diffuse Large B Cell Lymphoma, Disease Attributes, +25 more
- Locations
-
- Tohoku University Hoaspital Sendai, Miyagi, Japan
- Aichi Cancer Center Hospital Aichi, Japan
- NHO Nagoya Medical Center Aichi, Japan
- National Cancer Center Hospital East Chiba, Japan
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
NCT04464200
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States